title: Hemodynamic changes in patients developing effective hypovolemia after total paracentesis.
abstract: OBJECTIVE
  In many centers paracentesis is considered the treatment of choice for tense ascites. However, the mechanism of effective hypovolemia after paracentesis, the main complication associated with this procedure, remains unknown. In the current study, systemic hemodynamics was sequentially studied before and after total paracentesis in 46 patients with cirrhosis and tense ascites. The aim of the study was to assess the mechanism of effective hypovolemia after paracentesis.
  
  
  METHODS
  Plasma renin activity and aldosterone, mean arterial pressure, cardiac output (ECO-Doppler) and systemic vascular resistance were measured before, and 3 h, 6 h and 6 days after total paracentesis associated with plasma volume expansion.
  
  
  RESULTS
  Effective hypovolemia after paracentesis (defined as 50% increase in plasma renin activity up to a level over 4 ng x m(-1) x h(-1) at the 6th day after paracentesis) occurred in 20 cases [plasma renin activity increased from 8+/-17 to 19+/-2.7 ng x m(-1) x h(-1)]. In the remaining 26 cases no changes in plasma renin activity [8.5+/-2.4 vs. 8.7+/-2.2 ng x m(-1) x h(-1)] were observed. The amounts of ascitic fluid volume removed were similar. Effective hypovolemia after paracentesis was associated with a significant decrease in mean arterial pressure (89+/-2 vs. 81+/-3 mmHg) and systemic vascular resistance [1263+/-67 vs. 1014+/-80 dyn x s(-1) x cm(-5)] 6 days after treatment. In contrast, no significant changes in these parameters were observed in patients not developing this complication. In the whole group of patients a significant inverse relation was observed between changes in plasma renin activity and in systemic vascular resistance (r=0.74;p< 0.001).
  
  
  CONCLUSIONS
  These results indicate that effective hypovolemia after paracentesis in cirrhosis is predominantly due to an accentuation of the arteriolar vasodilation already present in these patients.
authors.affiliation: Service of Gastroenterology, Hospital del Mar, Universitat Autònoma de Barcelona, Spain.
authors.forename: M C
authors.initials: MC
authors.lastname: Vila
authors.forename: R
authors.initials: R
authors.lastname: Solà
authors.forename: L
authors.initials: L
authors.lastname: Molina
authors.forename: M
authors.initials: M
authors.lastname: Andreu
authors.forename: S
authors.initials: S
authors.lastname: Coll
authors.forename: J
authors.initials: J
authors.lastname: Gana
authors.forename: J
authors.initials: J
authors.lastname: Marquez
authors.forename: J
authors.initials: J
authors.lastname: Palá
authors.forename: F
authors.initials: F
authors.lastname: Bory
authors.forename: S
authors.initials: S
authors.lastname: Pons
authors.forename: L
authors.initials: L
authors.lastname: Szescielinski
authors.forename: W
authors.initials: W
authors.lastname: Jimenez
mesh_terms: D000328:Adult; D000368:Aged; D000450:Aldosterone / Q000097:blood; D000704:Analysis of Variance; D001201:Ascites / Q000503:physiopathology* / Q000628:therapy; D001794:Blood Pressure / Q000502:physiology; D001810:Blood Volume; D002302:Cardiac Output; D005260:Female; D006439:Hemodynamics / Q000502:physiology*; D006801:Humans; D016014:Linear Models; D008103:Liver Cirrhosis / Q000503:physiopathology* / Q000628:therapy; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D019152:Paracentesis / Q000009:adverse effects*; D012083:Renin / Q000097:blood; D014655:Vascular Resistance / Q000502:physiology
chemical_list: D000450:Aldosterone; D012083:Renin